1. Biogen earnings + surprise news about Alzheimer’s drug aducanumab — Bristol-Myers makes Opdivo pitch for frontline lung cancer — Criticism of ProPublica’s latest analysis of physician payment data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Merck Ophthalmics

Discussion in 'Ophthalmology' started by Anonymous, Feb 28, 2007 at 5:30 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What's this I hear that Merck is going to try this experiment one more time? Are they crazy? 3times and your out!